Baader Bank Aktiengesellschaft’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Baader Bank Aktiengesellschaft's EW Position: Q2 2026 in Review
Baader Bank Aktiengesellschaft reduced its Edwards Lifesciences (EW) stake by 12% in Q2 2026, selling an estimated $765K and leaving 66,430 shares worth $6.01M. The position accounts for 0.45% of the portfolio, ranked #55.
Baader Bank Aktiengesellschaft first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $13.8M in Q1 2024. 1,332 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Baader Bank Aktiengesellschaft held 66,430 shares of Edwards Lifesciences worth $6.01M as of Q2 2026.
- Baader Bank Aktiengesellschaft sold 9,131 Edwards Lifesciences shares in Q2 2026, an estimated $765K.
- Edwards Lifesciences made up 0.45% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #55 holding.
- Baader Bank Aktiengesellschaft first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
- Baader Bank Aktiengesellschaft's Edwards Lifesciences position peaked at $13.8M in Q1 2024.
- 1,332 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.